|
Volumn 21, Issue 8, 2002, Pages 632-634
|
Combined antifungal treatment of visceral mucormycosis with caspofungin and liposomal amphotericin B
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHOTERICIN B LIPID COMPLEX;
BICARBONATE;
CASPOFUNGIN;
CEFOTIAM;
CIPROFLOXACIN;
DOBUTAMINE;
IMIPENEM;
INSULIN;
METRONIDAZOLE;
NORADRENALIN;
RIFAMPICIN;
VANCOMYCIN;
ACUTE HEMORRHAGIC PANCREATITIS;
ADOLESCENT;
ANTIBIOTIC THERAPY;
ANURIA;
ARTICLE;
ARTIFICIAL VENTILATION;
BACTERIAL INFECTION;
CASE REPORT;
CELL WALL;
CLINICAL FEATURE;
CONTROLLED STUDY;
DEATH;
DISEASE COURSE;
DRUG MECHANISM;
ENTEROCOCCUS FAECIUM;
FEMALE;
FUNGAL CELL;
FUNGUS GROWTH;
HEMODIALYSIS;
HUMAN;
HYPERGLYCEMIA;
HYPERLIPIDEMIA;
HYPOTENSION;
INOTROPISM;
KIDNEY FAILURE;
LAVAGE;
LIVER DISEASE;
LIVER FAILURE;
METABOLIC ACIDOSIS;
MUCORALES;
MUCORMYCOSIS;
PANCREAS SURGERY;
PERITONEAL CAVITY;
PLASMAPHERESIS;
PRIORITY JOURNAL;
RHIZOPUS;
SMALL INTESTINE DISEASE;
TRACHEOSTOMY;
ADOLESCENT;
AMPHOTERICIN B;
ANTI-BACTERIAL AGENTS;
ANTIFUNGAL AGENTS;
DRUG THERAPY, COMBINATION;
FATAL OUTCOME;
FEMALE;
HUMANS;
MUCORMYCOSIS;
PEPTIDES;
PEPTIDES, CYCLIC;
RHIZOPUS;
|
EID: 0036039083
PISSN: 09349723
EISSN: None
Source Type: Journal
DOI: 10.1007/s10096-002-0781-6 Document Type: Article |
Times cited : (29)
|
References (8)
|